Abstract Contact lenses (CLs) are prone to adhesion and invasion by pollutants and pathogenic bacteria, leading to infection and inflammatory diseases. However, the functionalization of CL (biological functions such as anti-fouling, antibacterial, and anti-inflammatory) and maintaining its transparency still face great challenges. In this work, as a member of the MXenes family, vanadium carbide (V[2]C) is modified onto CL via a water transfer printing method after the formation of a tightly arranged uniform film at the water surface under the action of the Marangoni effect. The coating interface is stable owing to the electrostatic forces. The V[2]C-modified CL (V[2]C@CL) maintains optical clarity while providing good biocompatibility, strong antioxidant properties, and anti-inflammatory activities. In vitro antibacterial experiments indicate that V[2]C@CL shows excellent performance in bacterial anti-adhesion, sterilization, and anti-biofilm formation. Last, V[2]C@CL displays notable advantages of bacteria elimination and inflammation removal in infectious keratitis treatment. __________________________________________________________________ Water transfer printing of 2D MXene onto contact achieved high transmittance, anti-inflammatory, and antibacterial properties. INTRODUCTION Contact lenses (CLs) and orthokeratology (OK) lenses have played an important role in refractive correction for myopia patients. On the basis of material composition, CL can be classified as either rigid gas-permeable lenses fabricated from silicone and fluorine polymers or soft hydrogel and silicone hydrogel lenses. Approximately 140 million patients worldwide choose to wear CL instead of frame glasses each year because of their advantages, such as aesthetics, ease of movement, and low cost ([42]1). In the context of the increasingly widespread use of electronic products, myopia in adolescents has shown a high incidence trend in recent years ([43]2). According to a survey by the National Health Commission, the overall myopia rate among children and adolescents in China is 52.7%, with 14.3% for 6-year-old children, 35.6% for primary school students, 71.1% for middle school students, and 80.5% for high school students, respectively ([44]3). OK lenses are made of hard corneal CL materials with high oxygen permeability ([45]4). Wearing OK lenses at night flattens the central part of the cornea, which can shorten the eye axis and gradually flatten the cornea’s curvature. Thus, patients can achieve clear vision during the day without wearing glasses. Notably, as a physical therapy method for myopia correction, OK lenses have become one of the most common methods for myopia correction ([46]5, [47]6). In addition, cosmetic CLs, also known as colored CLs, are popular lenses that can change the color and size of the pupils, helping to enhance the appearance of the wearer, and are loved by young consumers ([48]7, [49]8). However, prolonged CL wear and unhealthy ocular habits greatly increase the risk of bacterial adhesion to CL, predisposing to biofilm formation ([50]9). The bacteria in the biofilms avoid the killing of lysozyme that initially existed in tears. Compared to free bacteria, bacteria within the biofilms have increased antibiotic resistance by more than 500 to 1000 times ([51]10, [52]11). The proliferation and invasion of bacteria will further lead to the occurrence of infectious keratitis ([53]12, [54]13). To mitigate surface contamination issues with CL, coating modifications have emerged as a principal technology for enhancing anti-fouling performance and extending service life. For example, polyethylene glycol, heparin, zwitterion, and other hydrophilic coatings were constructed by chemical reactions on CL surfaces through “grafting to” and “grafting from” technologies ([55]14). The monolayer or layer-by-layer coating with interface effect can also be prepared onto CL surfaces by supermolecule self-assembly technology ([56]15, [57]16). Another type of surface modification technology is the construction of biomimetic coatings onto CL surfaces, including self-polymerization coatings of dopamine ([58]17) and derivatives resembling mussels ([59]18, [60]19), nacre-inspired mineralized films ([61]20), and barnacle-like coatings ([62]21). Among them, our team combined super spreading and biomineralization to construct a transparent and mechanically robust underwater superoleophobic film on the surface of optical materials ([63]20). Similarly, we constructed a transparent and biocompatible amyloid-like nanofilm on the CL surface. The nanofilm was used to encapsulate and release cyclosporin A for dry eye syndrome treatment, which displayed excellent therapeutic efficacy with an 82% increase in drug bioavailability ([64]21). However, the process of chemical modification is relatively cumbersome, which can easily lead to a decrease in the transparency of the CL. The preparation process of biomimetic-modified coatings is simple with high light transmittance, but they rarely have biological functions such as sterilization and anti-inflammatory properties. It is still a problem to be solved how to modify the surface of the CL with transparency and endow it with anti-fouling, bactericidal, and anti-inflammatory properties. Our previous review mentioned that traditional antibacterial interfaces mainly include three types of surfaces: anti-fouling surface, contact-killing surface, and bactericide release surface ([65]11). On this basis, composite functional antibacterial surfaces and intelligent antibacterial surfaces responsive to bacterial infection microenvironments have also been derived ([66]22, [67]23). For example, we have constructed an antibiotic-loaded coating on the CL surface by surface-initiated reversible addition-fragmentation chain transfer polymerization ([68]24). The reversible conversion of pH-responsive dynamic chemical bonds in the coating realizes multiple loading and intelligent release of antibiotics. In addition, researchers have reported the antibacterial functionalization modification of biomaterial interfaces by drug sustained release coatings responsive to highly expressed enzymes in the infected microenvironment ([69]25). In physiological environments such as body fluids or blood, bacterial adhesion is regarded as the critical initial step in biofilm formation ([70]26, [71]27). Once bacteria achieve a transition from reversible adhesion to irreversible adhesion, it will inevitably lead to biofilm formation and the development of bacterial resistance. Therefore, an antibacterial interface with both anti-adhesion and bactericidal effects is very beneficial to the safe use of CLs. In addition, when infection occurs, it inevitably leads to inflammatory reactions and tissue damage. Once the cornea is damaged or its transparency decreases, it cannot return to the normal morphological structure ([72]28, [73]29). Oxidative stress plays an important immune regulatory role in the inflammatory response process related to infection, such as bacteria-killing by oxidative free radicals (ROS, reactive oxygen species). However, oxidative stress is also essential in exacerbating inflammatory reactions, which also leads to corneal tissue damage. It has been proved that eliminating oxidative stress while killing bacteria to reduce inflammation can promote the repair of infected wounds ([74]30, [75]31). Among the newly reported antibacterial materials, two-dimensional (2D) materials including graphene and its derivatives, black scales, layered double hydroxides (LDHs), transition metal chalcogenide (TMDs), and 2D transition metal carbides (MXenes) ([76]32) have attracted tremendous attention in the field of material science. Two-dimensional materials used for antibiosis have advantages such as good biocompatibility, high sterilization efficiency, and no drug resistance development owing to multiple sterilization mechanisms including physical/mechanical damage, lipid extraction, oxidative stress, and photothermal/photodynamic effects ([77]33). For example, self-activating implants modified with hydroxyapatite/MoS[2] coating present a high antimicrobial efficacy against both Staphylococcus aureus and Escherichia coli because of bacterial respiration-activated metabolic pathway changes ([78]34). Two-dimensional MXenes, such as vanadium carbide (V[2]C) and niobium carbide, exhibit excellent reducibility and catalase (CAT)-like and superoxide dismutase (SOD)–like activities ([79]35, [80]36). A face-to-face water transfer printing technology is so far the only known way to accomplish both the growth and transfer steps of 2D single-layer film. In addition, this surface modification technique is compatible with arbitrary sizes and shapes of the substrate. For example, face-to-face water transfer printing technology has been applied to prepare a large-scale uniform graphene film on a flexible polyimide substrate ([81]37). In this work, V[2]C 2D MXenes were modified onto the CL surfaces through face-to-face water transfer printing technology ([82]Fig. 1A). Briefly, V[2]C MXene nanosheets (NSs) were obtained through hydrofluoric acid (HF) etching of bulk MAX-phase V[2]AlC ceramics and tetrapropylammonium hydroxide (TPAOH) intercalation. The CL was endowed with positive charge properties by polyethyleneimine (PEI) amination pretreatment to combine with unilaminar V[2]C through electrostatic interactions (V[2]C@CL). The uniform V[2]C coating displayed strong anti-adhesion, bactericidal, and anti-biofilm effects against both Gram-positive bacteria methicillin-resistant S. aureus (MRSA) and Gram-negative bacteria E. coli. The V[2]C@CL also showed excellent anti-inflammatory activity through the elimination of ROS based on its CAT-like, SOD-like, and glutathione peroxidase (GPx)–like activities. Notably, in the infectious keratitis treatment animal model, V[2]C@CL with both bactericidal and anti-inflammatory functions showed obvious advantages in infectious wound healing and corneal tissue protection ([83]Fig. 1B). Fig. 1. Schematic illustration of V[2]C@CL preparation and application. [84]Fig. 1. [85]Open in a new tab (A) The process of preparing V[2]C@CL using the water transfer printing method. (B) Multifunctional properties of V[2]C@CL in prevention and treatment of infectious keratitis. PEI, polyethyleneimine; IL-1β, interleukin-1β; NF-κB, nuclear factor κB; TNF-α, tumor necrosis factor–α. RESULTS Preparation and characterization of V[2]C@CL As shown in [86]Fig. 2A, Al atoms were etched from the V[2]AlC MAX phase in HF solution to obtain multilayer V[2]C (mV[2]C). The obtained blocky precipitates were added to TPAOH aqueous solution for intercalation, and the supernatant was collected to obtain V[2]C MXene NSs aqueous solution. Compared to the block structure of V[2]AlC (fig. S1A) and the multilayer structure of mV[2]C (fig. S1B), the transmission electron microscopy (TEM) image of fully peeled V[2]C MXene NSs showed single-layer and 2D sheet-like structure ([87]Fig. 2B). Selected area electron diffraction (SAED) patterns further showed the well-defined polycrystalline structure of V[2]C MXene NSs ([88]Fig. 2C). The crystal forms of V[2]AlC and V[2]C were measured through x-ray diffraction (XRD) spectroscopy analysis ([89]Fig. 2D). XRD patterns revealed characteristic peaks at 13.70° and 41.46° in V[2]AlC, corresponding to the (002) and (103) crystal forms, respectively. Following etching, these signature V[2]AlC peaks were absent in the diffractogram of the resulting V[2]C material. A previously unidentified peak emerged at 7.54° in the V[2]C diffractogram, indicating the (002) crystalline phase. In the final dispersion of V[2]C MXene NSs, the predominant fraction of V[2]C NSs exhibited successful layering, with virtually no unreacted MAX phase impurities remaining. In addition, high-resolution TEM (HRTEM) unveiled the micro-lattice structure of V[2]C MXene NSs ([90]Fig. 2E) with a lattice spacing of 0.24 nm, thereby confirming the successful synthesis of V[2]C MXene NSs. The V[2]C MXene NSs exhibited a negative charge, as evidenced by a zeta potential of −38 ± 20 mV ([91]Fig. 2F), which was attributed to the presence of =O and -OH functional groups on the MXene surface. The inherent negative charges on the V[2]C MXene surface facilitated its interaction with positively charged CL, which had been pretreated through PEI amination. Fig. 2. Preparation of V[2]C MXene NSs and characterization of V[2]C MXene NSs and V[2]C@CL. [92]Fig. 2. [93]Open in a new tab (A) Illustration of the preparation of V[2]C MXene NSs. (B) Transmission electron microscopy (TEM) image, (C) selected area electron diffraction image, (D) x-ray diffraction patterns, (E) high-resolution TEM image, and (F) zeta potential of V[2]C MXene NSs. (G) Scanning electron microscopy (SEM) images of CL, V[2]AlC@CL, mV[2]C@CL, V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL. (H) Transmittance was assessed by an ultraviolet-visible (UV-Vis) spectrometer. (I and J) Typical x-ray photoelectron spectroscopy full-spectrum and V2p spectrum of V[2]C-1@CL. (K) SEM elemental mapping of V[2]C-1@CL. Subsequently, we used the face-to-face water transfer printing method to modify the positively charged CL surface with one to three layers of V[2]C to obtain V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL, respectively. Through the same steps, the V[2]AlC MAX phase without HF etching and mV[2]C without TPAOH intercalation was modified on the CL surface to obtain V[2]AlC@CL and mV[2]C@CL to be used as control. In the face-to-face water transfer printing process, the V[2]C MXene NS ethanol dispersion was slowly dripped into a glass dish containing deionized water (0.1 ml/s). Under the influence of the Marangoni effect, V[2]C MXene NSs rapidly diffused and formed a continuous thin film at the gas-liquid interface. Tweezers were used to clamp the edge of CL horizontally to slowly press down on the water and quickly lift it up to transfer the film onto the outer surface of CL. The CL was then folded to make the inner surface protrude, and V2C MXene was transferred onto the inner CL surface in the same way. The surface moisture was blown dry with nitrogen gas to obtain a single-layer V[2]C MXene NS–coated CL. This process was iterated to produce CLs coated with two and three layers of V[2]C MXene. As depicted in [94]Fig. 2G, scanning electron microscopy (SEM) imaging of CLs subjected to different coatings revealed that the surfaces of V[2]AlC@CL and mV[2]C@CL exhibited rough and uneven textures, while V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL essentially maintained their surface flatness. It is well known that the smoothness and flatness of the coating notably influences the transparency of CLs. To assess this, CLs modified by different kinds of coatings were placed on color printing paper, black and white printing paper, and gauze to evaluate the clarity of text and texture. A notable reduction in light transmittance was observed in V[2]AlC@CL and mV[2]C@CL groups due to the uneven coatings of V[2]AlC and mV[2]C. In contrast, V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL consistently maintained satisfactory transparency of text, color, and texture, akin to unmodified CL (fig. S2). This observation was further substantiated by ultraviolet-visible (UV-Vis) spectroscopy. Compared to V[2]AlC@CL and mV[2]C@CLwith transmittance below 60%, the transmittance of V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL all exceeded 80% ([95]Fig. 2H). To ensure adequate optical performance of CL, three-layer V[2]C was considered to be the limited number of layers for CL modification. Ellipsometry tests showed that the coating thicknesses of one-, two-, and three-layer V[2]C were 9.16 ± 0.65 nm, 16.42 ± 0.23 nm, and 30.09 ± 0.75 nm, respectively (fig. S3). The electrokinetic analyzer for solid surface analysis demonstrated that the zeta potential of the CL surface increased from −31.25 ± 0.39 mV to 35.52 ± 1.31 mV after PEI modification. In addition, the zeta potentials were measured as 4.33 ± 1.06 mV, −13.11 ± 1.69 mV, and −20.09 ± 1.22 mV for the V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL surfaces, respectively (fig. S4). Furthermore, after modification, the water contact angle of V[2]C-1@CL decreased from 42.35° ± 0.75° to 15.5° ± 0.1° (fig. S5). Therefore, V[2]C@CL exhibited good hydrophilicity, which would provide improved wearing comfort. To simulate the shearing force of eyelids on CL, V[2]C-1@CL was rinsed with a water flow (10 ml/s). After 12 hours, V[2]C-1@CL retained favorable hydrophilicity with a mean contact angle of 24.97° (fig. S6). To further assess coating stability, V[2]C-1@CL was immersed in pH 4 (HCl) and pH 10 (NaOH) solutions for 12 hours. Subsequent contact angle measurements confirmed the retained hydrophilicity. Thus, coating persistence under both acidic and basic conditions demonstrated the stability of the V[2]C MXene coating (fig. S7). Then, x-ray photoelectron spectroscopy (XPS) was used to analyze the types and valence states of elements on the surface of V[2]C@CL ([96]Fig. 2I). The XPS analysis showed binding energy absorption peaks at 516, 400, 153, and 102 eV, attributed to V2p, N1s, Si2s, and Si2p, respectively. These peaks originated from the V[2]C coating, pretreated PEI, and the intrinsic silicon hydrogel composition of CLs. In addition, peak fitting of the V2p region revealed that most V elements existed in the V^5+ oxidation state with binding energies at 516.3 and 523.7 eV ([97]Fig. 2J). A minor fraction of V^4+ was also detected as indicated by the two fitting peaks at 513.3 and 520.6 eV, respectively. The high valence state of V in V[2]C@CL was due to the presence of oxygen-containing groups and oxidized monolayers on the surface of V[2]C MXene. SEM element mapping and corresponding elemental analysis were conducted to explore the types and distribution of elements on the V[2]C@CL surface ([98]Fig. 2K and fig. S8). The results showed that V[2]C and PEI were uniformly distributed on the CL surface with V and N as the characteristic elements, respectively. This observation confirmed that the uniform and high-density modification of CL with high transparency was successfully achieved through PEI pretreatment and face-to-face water transfer printing method. Biomimetic enzyme activity of V[2]C@CL In this part, the biological enzyme-like activities of V[2]C@CL were explored including CAT-like, SOD-like, and GPx-like activities, which could eliminate overexpressed ROS in the microenvironment when infection and inflammation occurred. Among them, hydrogen peroxide (H[2]O[2]) was the main component of ROS and the substrate for further formation of free radical components. As illustrated in [99]Fig. 3A, oxygen (O[2]) and water (H[2]O) were the products during the catalytic decomposition of H[2]O[2] by V[2]C. To indirectly gauge the catalytic activity of each sample group, the amount of generated O[2] was quantified using a dissolved O[2] analyzer. As demonstrated in [100]Fig. 3G, CL and V[2]AlC@CL exhibited no CAT-like activity, and mV[2]C@CL only displayed minimal CAT-like activity. In contrast, V[2]C@CL exhibited robust CAT-like activity with O[2] production in a time-dependent pattern. Notably, as the number of V[2]C layers increased, the catalytic performance was strongly enhanced. Likewise, the CAT-like activity of V[2]C@CL was assessed through quantification of residual H[2]O[2] in the system using the H[2]O[2] assay kit ([101]Fig. 3D and fig. S9). V[2]C@CL exhibited excellent CAT-like activity compared to V[2]AlC@CL and mV[2]C@ CL. Moreover, V[2]C-2@CL and V[2]C-3@CL also exhibited significantly enhanced activity compared to V[2]C-1@CL. However, considering the transparency of CL and the already obtained high enzymatic catalytic activity, the number of V[2]C layers modified onto CL was not further increased. Fig. 3. Biomimetic enzyme activity of V[2]C@CL. [102]Fig. 3. [103]Open in a new tab (A to C) Schematic illustration of CAT-like activity, SOD-like activity, and GPx-like activity of V[2]C@CL. (D to F) CAT-like activity, SOD-like activity, and GPx-like activity of different CL. (G) The time-dependent evolution of O[2] generation resulting from H[2]O[2] decomposition under different treatments. (H) total antioxidant capacity (T-AOC) of different CL. (I) Ultraviolet radiation-inhibition activity of different CL. Data are presented as means ± SD, n = 3, biological replicate, and significances are determined by one-way analysis of variance (ANOVA) with Tukey’s correction. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; ns, no significance. Furthermore, superoxide radicals (•O[2]^−) are persistent ROS produced during the normal physiological activities of life metabolism, and their expression level significantly increases during infection and inflammatory reactions. As a key antioxidant enzyme against ROS in cells, SOD catalyzes the disproportionation of •O[2]^− to generate O[2] and H[2]O[2] to reduce oxidative stress ([104]Fig. 3B). Therefore, SOD mimics are used as potential therapeutic agents to combat inflammatory diseases caused by oxidative stress ([105]38). The test results showed that the SOD-like activity of V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL was 34.34, 45.94, and 61.13%, respectively, demonstrating much higher biomimetic enzyme activity than that in the control groups ([106]Fig. 3E and fig. S10). In addition, GPx used intracellular tripeptide glutathione (GSH) as a reducing agent to catalyze the decomposition of H[2]O[2] into H[2]O, while oxidizing GSH to glutathione (GSSG). GSSG is reduced to GSH with the assistance of glutathione reductase and coenzyme nicotinamide adenine dinucleotide phosphate. Therefore, GPx played a crucial role in maintaining H[2]O[2] levels in the body ([107]Fig. 3C). The GPx kit was used to test the GPx-like enzyme activity of CLs in each group. The test results demonstrated that the GPx activity of V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL was 51.88, 62.99, and 76.95%, respectively ([108]Fig. 3F and fig. S11). The total antioxidant capacity (T-AOC) of V[2]C@CL was measured using the Total Antioxidant Capacity Assay kit with ABTS as an indicator. As displayed in [109]Fig. 3H, the T-AOC of V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL reached 44.07, 52.5, and 64%, respectively. UV radiation was also used to stimulate the generation of ROS, including hydroxyl radical (•OH) and H[2]O[2]. The CLs in each group were submerged in phosphate-buffered saline (PBS) and exposed to UV irradiation for 30 min to evaluate the UV protective capabilities of V[2]C@CL. As illustrated in [110]Fig. 3I, the quantification of produced ROS within each system was determined using 3, 3′, 5, 5′-tetramethylbenzidine (TMB) as an indicator. The result showed that V[2]C@CL significantly reduced the generation of ROS under UV irradiation. In comparison, the enzyme activities were negligible in the CL, V[2]AlC@CL, and mV[2]C@CL control groups. Therefore, it indicated that V[2]C could only exhibit various biomimetic enzyme activities in a monolayer state rather than in a stacked state. A uniform large-scale single-layer V[2]C film was obtained through the face-to-face water transfer printing method onto CL surfaces, providing sufficient specific surface area for substrate catalysis. In vitro cytocompatibility, antioxidant, and anti-inflammatory properties After incubation of human corneal epithelial cells (HCECs) with different types of CL for 24 hours, both cell live/dead staining and Cell Counting Kit-8 (CCK-8) methods were used to conduct the biocompatibility testing. The live/dead staining images showed that most of the cells in each group exhibited green fluorescence representing live cells, while the dead cells were minimal with red fluorescence ([111]Fig. 4A). The CCK-8 results showed that the survival rate of cells cultured in each group was greater than 90% compared with the original CL, displaying no significant cytotoxicity in various groups ([112]Fig. 4B). Therefore, different types of CL sample all showed good cell compatibility. Then, the intracellular oxidative stress of HCECs induced by H[2]O[2] was used to detect the ROS scavenging effect of various coatings using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) as a fluorescent probe. As indicated in [113]Fig. 4C, clear green fluorescence appeared in CL-, V[2]AlC@CL-, and mV[2]C@CL-treated groups, indicating intracellular produced ROS in HCECs stimulated by H[2]O[2]. However, in the V[2]C-1@CL–, V[2]C-2@CL–, and V[2]C-3@CL–treated groups, there was almost no green fluorescence, indicating the elimination of intracellular ROS by V[2]C with various enzyme-like activities. In addition, immunofluorescence staining of the DNA damage marker γ-H2AX was conducted after H[2]O[2] induction of HCECs. As shown in fig. S12, the green fluorescence intensity of HCECs in the V[2]C-1@CL–, V[2]C-2@CL–, and V[2]C-3@CL–treated groups was significantly lower than that in the control groups, which demonstrated the ROS scavenging ability of V[2]C@CL in DNA protection based on the efficient enzyme-like activity. Fig. 4. In vitro cytocompatibility, antioxidant, and anti-inflammatory properties of V[2]C@CL. [114]Fig. 4. [115]Open in a new tab (A) Live/dead cell staining of HCECs after 24-hour incubation with different CL. Green indicates live cells, and red indicates dead cells. (B) The cytocompatibility of different CL toward HCECs through CCK-8 examination. (C) Fluorescence micrographs of 2′,7′-dichlorofluorescin diacetate–stained HCECs after different treatments. (D) Fluorescence micrographs of IL-1β immunofluorescence staining of differently treated RAW 264.7 cells. (E to G) Enzyme-linked immunosorbent assay (ELISA) quantification of IL-1β, IL-6, and TNF-α in the cell culture medium of RAW 264.7 cells after different treatments. Data are presented as means ± SD, n = 3, biological replicate, and significances are determined by one-way ANOVA with Tukey’s correction. *P < 0.05, ***P < 0.001, and ****P < 0.0001. After infection, inflammatory reactions and oxidative stress in the immune system coexist and promote each other. Bacterial toxins stimulate lesional tissue and antigen-presenting cells to produce inflammatory cytokines and chemokines, which induces the recruitment of cytotoxic immune cells, including granulocytes, T cells, B cells, natural killer cells, and macrophages, to the lesion site. Immune cells kill pathogenic bacteria through the secretion of antibodies, oxidative stress, and phagocytosis. However, the simultaneous production of excessive ROS leads to oxidative stress in tissues, releasing cytokines and further exacerbating inflammatory reactions. In particular, if corneal tissue is damaged, then it is likely to cause a series of problems such as corneal defects, neovascularization, and scarring, ultimately leading to decreased corneal transparency. Therefore, if material-based killing effects replace or synergize immune killing effects while simultaneously reducing oxidative stress and inflammatory damage, then it may be a better treatment strategy to protect the integrity and transparency of the cornea. To verify this concept, RAW 264.7 cells were stimulated by lipopolysaccharide (LPS) and cultured with different groups of CLs. The expression of various intracellular inflammatory factors including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor–α (TNF-α) was observed after immunofluorescence staining ([116]Fig. 4D and figs. S13 and S14). It was found that the cells in the CL-, V[2]AlC@CL-, and mV[2]C@CL-treated groups showed obvious green fluorescence, indicating the massive expressions of IL-1β, IL-6, and TNF-α inflammatory factors. When infection occurred, it mainly stimulated nuclear factor κB (NF-κB) inflammatory pathways to mediate the expression of various inflammatory factors. However, in the V[2]C-1@CL–, V[2]C-2@CL–, and V[2]C-3@CL–treated groups, the green fluorescence was significantly reduced, indicating the highly reduced expressions of IL-1β, IL-6, and TNF-α, which certified the anti-inflammatory effect through eliminating oxidative stress. To further validate the anti-inflammatory effect, the culture media of RAW 264.7 cells were collected after different treatments, and inflammatory factors were quantitatively analyzed using an enzyme-linked immunosorbent assay (ELISA) kit ([117]Fig. 4, E to G). The significantly reduced expressions of IL-1β, IL-6, and TNF-α inflammatory factors were found in V[2]C-1@CL–, V[2]C-2@CL–, and V[2]C-3@CL–treated groups. In addition, compared to the expressions of inflammatory factors in CL and V[2]AlC@CL groups, only slightly reduced expressions were observed in the mV[2]C@CL group. This result was well consistent with the above immunofluorescence tests. In summary, on the basis of the CAT-like, SOD-like, and GPx-like activities, V[2]C@CL could catalyze ROS decomposition in cells stimulated by LPS to reduce the inflammatory response. The expressions of inflammatory mediators further decreased with the increase of the V[2]C layer number. Anti-adhesion, bactericidal, and anti-biofilm properties In complex pathophysiological environments, biomaterials are susceptible to direct protein contact, further mediating bacterial adhesion. Once the bacteria colonize the material surface, they complete quantitative proliferation and extracellular matrix (ECM) secretion forming the initial state of the biofilms. Then, mushroom-like bacterial colonies continue to grow and interact with each other, which are regulated by the quorum sensing system to form a mature biofilm growth ecosystem ([118]27). Therefore, bacterial adhesion to the material interface is considered the initial and most important step in biofilm formation. To test the anti-adhesion ability, the CLs in each group were incubated with MRSA and E. coli solutions, respectively. After washing off the planktonic bacteria, the attached bacteria were further dissociated from the CL through ultrasound to form a bacterial suspension. The content of bacteria was measured by plate counting method to determine the anti-adhesion ability of CLs in each group. As shown in [119]Fig. 5, A and B, both initial CL and V[2]AlC@CL basically showed no anti-adhesion effect to MRSA and E. coli. Meanwhile, mV[2]C@CL also showed a limited anti-adhesion effect with a large amount of bacterial adhesion on CL. However, V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL all exhibited excellent anti-adhesion effects with adhesion rates of 8.98, 1.81, and 0.9% to MRSA and 22.11, 5.47, and 0.95% to E. coli, respectively. Fig. 5. Anti-adhesive properties of V[2]C@CL. [120]Fig. 5. [121]Open in a new tab (A and B) Images of bacterial colonies on agar plates and quantitative analysis of adhesion rate of bacteria onto different CL. (C) Images of crystal violet staining of different CL after incubation with bacteria. (D) SEM images of bacteria adhering on different CL surfaces. Data are presented as means ± SD, n = 3, biological replicate, and significances are determined by one-way ANOVA with Tukey’s correction. ***P < 0.001 and ****P < 0.0001. To further determine the anti-adhesion ability of the coatings, the CLs were cultured with bacteria solutions and stained with crystal violet. Then, the CL surface was dyed blue-purple to quantify the adhered bacteria and secreted ECM. As shown in [122]Fig. 5C, the purple color on the surface of V[2]AlC@CL was even darker than that on the initial CL. The quantification of crystal violet staining showed that MRSA and E. coli adhesion on V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL surfaces accounted for 22.01, 15.07, 5.56% and 20.96, 12.79, 7.67%, respectively, of that adhered on pristine CL surfaces (fig. S15). Because of the rough surface fit for bacterial adhesion, the depth of purple on mV[2]C@CL and V[2]AlC@CL surfaces only negligibly decreased compared to that of pristine CLs, indicating the absence of bacterial anti-adhesion ability. On the contrary, there was basically no purple color on the surfaces of V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL, indicating that bacteria could not adhere to the single-layer 2D V[2]C surface. A similar result was also found in live/dead staining of MRSA and E. coli on CL surfaces (fig. S16). There was a large amount of green fluorescence with very little red fluorescence on initial CL, V[2]AlC@CL, and mV[2]C@CL surfaces indicating the live state of bacteria. In contrast, a remarkable increase in red fluorescence and substantially decreased green fluorescence on V[2]C@CL surfaces showed significant anti-adhesion and bactericidal effects. Fluorescence quantification analysis revealed green fluorescence was reduced by 71.15, 80.02, and 94.02% for MRSA and 78.29, 88.18, and 96.17% for E. coli on V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL surfaces compared to that on initial CL surface, respectively. In addition, the bacterial adhesion on various CL surfaces was visually displayed through SEM testing ([123]Fig. 5D). As shown in the SEM images, a large number of bacteria accumulated on pristine CL, V[2]AlC@CL, and mV[2]C@CL surfaces. Furthermore, there was only a small number of bacteria on V[2]C-1@CL and V[2]C-2@CL surfaces, while there was basically no bacteria adhering to the surface of V[2]C-3@CL. On the one hand, the uniform coverage of V[2]C onto the CL surface was achieved through the face-to-face water transfer printing method. On the other hand, the single-layer V[2]C was not conducive to bacterial adhesion. In addition, the CLs in each group were incubated with MRSA and E. coli separately, and the bacterial solutions were plated to enumerate viable cells (fig. S17). The results showed that V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL exhibited killing efficacy of 51.20, 70.34, and 84.82% against MRSA and 59.44, 76.86, and 87.21% against E. coli, respectively, demonstrating potent bactericidal capabilities of V[2]C MXene coating. Further exploration of anti-adhesion and bactericidal mechanisms was conducted through RNA sequencing (RNA-seq) methods. Furthermore, biofilm formation and the survival of bacteria on CL surfaces were identified using a live/dead staining method after long-term contact culture of modified CL with bacterial solutions (72 hours). Laser scanning confocal microscopy was used to observe the 3D biofilm morphology on CL surfaces ([124]Fig. 6A) and the ratio of red and green fluorescence intensity ([125]Fig. 6, B and C). The 3D structure observation showed that the formed biofilms on the initial CL surface showed the largest thickness with mainly green fluorescence, indicating the survival of internal bacteria. Similarly, uniform and distinct viable bacterial biofilms formed on V[2]AlC@CL and mV[2]C@CL surfaces with predominating green fluorescence. These two modification methods could not resist bacterial adhesion or effectively kill bacteria within the biofilms. In addition, in the V[2]C-1@CL–treated group, it was found that 50.88% of MRSA and 36.13% of E. coli were stained with red fluorescence by fluorescence intensity statistical analysis. This indicated that V[2]C-1@CL played a good bactericidal role in the contact with bacteria. As the increase of V[2]C layer number onto the CL surface, the biofilms content on the CL surface further decreased, accompanied by a significant increase in the proportion of red fluorescence. The ratio of red fluorescence intensity on V[2]C-2@CL and V[2]C-3@CL surfaces were 57.44 and 78.91% for MRSA and 61 and 77% for E. coli, respectively. The green fluorescence intensities on V[2]C-2@CL and V[2]C-3@CL surfaces decreased by 79.13 and 92.94% for MRSA and by 83.56 and 96.35% for E. coli compared to initial CL, which indicated enhanced anti-adhesion and bactericidal effect as the increase of V[2]C layers. In particular, V[2]C-3@CL basically completely resisted the formation of E. coli biofilms and had the best bactericidal effect ([126]Fig. 6D). Fig. 6. Anti-biofilm properties of V[2]C@CL and MRSA RNA-seq analysis. [127]Fig. 6. [128]Open in a new tab (A) Confocal 3D images of biofilms on different CL surfaces with live and dead bacteria represented by green and red colors, respectively. (B and C) Relative fluorescence intensity of MRSA and E. coli biofilms on different CL surfaces. (D) Schematic illustration of the antibacterial mechanism for V[2]C@CL. (E) Volcano plots from RNA-seq analysis depicting differentially expressed genes between the CL and V[2]C-3@CL groups. (F) Heatmap depicting differentially expressed genes related to bacterial biofilm formation, virulence, proliferation, and drug resistance. (G and H) KEGG pathways analysis and GO analysis of differentially expressed genes between the CL and V[2]C-3@CL groups. As shown in [129]Fig. 5, the surface of V[2]C@CL could resist most of bacterial adhesion in the short term (for several hours). However, long-term CL wearing inevitably resulted in the adhesion of pollutants. Fortunately, V[2]C@CL could effectively kill the adhered bacteria on the surface to resist biofilm formation. The bactericidal effect and mechanism of 2D materials such as graphene and its derivatives have been reported in previous works ([130]39, [131]40). However, the bactericidal mechanism has not been clarified for 2D transition metal materials modified at the surface of biomaterials. Therefore, MRSA and E. coli were respectively cultivated with CL and V[2]C@CL, followed by RNA-seq of bacteria to explore the antibacterial mechanisms. As shown in [132]Fig. 6E and fig. S18, differential gene expression analysis revealed that after treatment by V[2]C-3@CL, 139 genes were up-regulated and 230 genes were down-regulated in MRSA. While 29 genes were up-regulated and 30 genes were down-regulated in E. coli. In addition, the analysis showed that the down-regulated genes in MRSA were associated with biofilm formation, virulence, proliferation, and drug resistance, while the down-regulated genes of E. coli were related to biofilm formation, virulence, and proliferation ([133]Fig. 6F and fig. S19). The V[2]C modification significantly inhibited bacterial biofilm formation and decreased bacterial virulence, proliferation, and drug resistance. Furthermore, we investigated the differentially expressed genes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analysis. KEGG is a database that contains information on genes and proteins, biochemical pathways, and regulatory pathways, which can be applied to check which of the differentially expressed genes belong to known KEGG pathways. If certain pathways are notably enriched, then it can reveal the biological processes or pathways that are most prominent and potentially important in the gene set. The enrichment of differentially expressed genes in 10 pathways was observed in KEGG pathway analysis ([134]Fig. 6G and fig. S20). The top three affected pathways in MRSA were glycolipid metabolism, limonene and pinene degradation, and ABC transporters. As for E. coli, the top three affected pathways were cationic antimicrobial peptide resistance, amino sugar and nucleotide sugar metabolism, and LPS biosynthesis. In addition, GO is a structured vocabulary to describe the biological processes, molecular functions, and cellular components associated with gene products. GO enrichment was determined by a similar analysis with GO terms instead of KEGG pathways. GO analysis of differentially expressed genes in MRSA showed that the three most relevant pathways were the plasma membrane, cell periphery, and nitrate metabolic process ([135]Fig. 6H). In E. coli, the top three relevant pathways were the biosynthetic process, plasmid maintenance, and protein glycosylation (fig. S21). On the basis of the above analysis, V[2]C@CL mainly damaged the cell membrane and other peripheral structures of bacteria, and acted on some metabolic pathways, thereby playing a significant role in bactericidal and anti-adhesion effects ([136]Fig. 6D). In vivo biocompatibility and antibacterial activity evaluation For animal experiments, V[2]C-3@CL was selected owing to its excellent biomimetic enzyme activity, anti-adhesion, bactericidal effects, and acceptable light transmittance (table S1). Before the animal model intervention experiment, the V[2]C-3–coated CL was worn on the eyes of Sprague-Dawley (SD) rats for biocompatibility evaluation by slit lamp, hematoxylin and eosin staining (H&E), and tonometer. As shown in [137]Fig. 7A, the blood vessel patterns of the cornea were clear after incubation with V[2]C-3@CL and initial CL. There was no significant transparency reduction compared with normal cornea, as well as no obvious edema, redness, and inflammatory reactions. It revealed that no punctate fluorescence formed on the cornea after sodium fluorescein staining (fig. S22). Tear film breakup time showed no significant difference among different groups (fig. S23). Further H&E staining observation showed that the corneal texture of the V[2]C-3@CL–treated group was clear compared with the normal cornea ([138]Fig. 7B). There was no significant increase in thickness and inflammatory infiltration cells, indicating the absence of significant inflammatory reaction in the cornea. The tear secretion test strip showed that there was no significant difference in the amount of tear secretion among the groups, indicating that CL wearing did not affect the stability of the tear film and tear secretion (fig. S24). In addition, there was no significant change in intraocular pressure (IOP) during material contact with the eye (fig. S25). Therefore, the above animal experiments verified good biocompatibility of V[2]C-3@CL to the eyes without significant biological irritation and toxicity. Fig. 7. In vivo biocompatibility evaluation of V[2]C@CL and therapeutic efficacy assessment of V[2]C@CL in a keratitis model using SD rats. [139]Fig. 7. [140]Open in a new tab (A) Slit lamp images of rat eyes on days 0, 1, 3, 5, 7, and 10 following different treatments. (B) Images of H&E-stained corneas from rats on day 10 after different treatments. (C) Schematic illustration depicting the in vivo assessment of therapeutic efficacy in an MRSA-infected keratitis model. (D and E) Images of bacterial colonies cultured from corneal homogenates on agar plates and quantification of viable bacteria remaining in corneas following different treatments. (F to H) Slit-lamp images, quantified corneal clinical scores (scales 0 to 20), and central corneal thickness from bacterially infected rats following different treatments on days 0, 1, 3, and 5. Data are presented as means ± SD, n ≥ 3, biological replicate, and significances are determined by one-way ANOVA with Tukey’s correction. *P < 0.05, **P < 0.01, and ***P < 0.001. In the animal experiment of infectious keratitis treatment, infectious corneal wounds were established the day before treatment ([141]Fig. 7C). Then, the initial CL, vancomycin, and V[2]C-3@CL were applied for 5 days of intervention, and the treatment process was tracked with the slit lamp, central corneal thickness, and inflammation score measurements. After treatment, electroretinography was used to observe the physiological function of the retina. Furthermore, after euthanasia, the cornea was fixed, sliced, and subjected to inflammatory factor expression and H&E staining tests. As shown in [142]Fig. 7F, there was no significant improvement in corneal transparency in the control group without intervention and the initial CL–treated group with the corneas remained in a state of edema, redness, and inflammatory response. In the vancomycin-treated group, the corneal keratitis state was significantly reduced on day 3, but there was still a large area of white lesions in the central area. Only in the V[2]C-3@CL–treated group did the inflammatory response of the cornea obviously reduce 1 day after treatment, and the lesion basically disappeared on day 5. The tracked clinical inflammation score and corneal center thickness showed that the corneas in V[2]C-3@CL–treated group displayed rapidly decreased clinical corneal score and inflammatory reaction ([143]Fig. 7, G and H). On day 5 after treatment, the inflammation score of corneas in the V[2]C-3@CL–treated group was around 2.5, indicating the basic disappearance of inflammatory response. The decreased corneal thickness illustrated the reduction of corneal edema symptoms. Similarly, it was found that the corneal thickness in the V[2]C-3@CL–treated group quickly decreased and had already returned to normal corneal thickness level on day 5 (below 200 μm). After treatment, corneal tissues were homogenized and diluted, and the bacterial was content quantified by plate counting. As depicted in [144]Fig. 7, D and E, the vancomycin-treated group displayed reduced bacterial content with a 61.93% decrease compared to the control group. In contrast, the V[2]C-3@CL–treated group exhibited an 86.40% decrease in bacterial content compared to the control group, resulting in the lowest bacterial level. Furthermore, electroretinography testing post-treatment revealed significantly reduced a-wave and b-wave amplitudes in the control, initial CL–, and vancomycin-treated groups, indicating substantial visual impairment. In contrast, the electroretinography spectrum of the V[2]C-3@CL–treated group retained high a-wave and b-wave amplitudes, suggesting maintenance of good visual function ([145]Fig. 8, A to C). Furthermore, the expressions of the classic inflammatory factors including IL-1β, IL-6, and TNF-α related to infection were analyzed using immunofluorescence ([146]Fig. 8D). Compared to a large amount of red fluorescence in the corneal region in the control, initial CL–, and vancomycin-treated groups, only the corneas in the V[2]C-3@CL–treated group showed almost no red fluorescence indicating the subsided inflammatory response. In addition, the real-time quantitative polymerase chain reaction (qRT-PCR) method was used to analyze the expression of mRNA related to inflammatory factors ([147]Fig. 8F). Compared to the control group, the mRNA expressions related to IL-1β, IL-6, and TNF-α in the V[2]C-3@CL–treated group significantly decreased by 79.33, 65.72, and 82.7%, respectively. Therefore, after V[2]C-3@CL treatment, effective bacterial infection elimination significantly reduced the expression of inflammatory factors. Then, H&E staining of corneal slices was also performed to observe the morphology and structure of the cornea, as well as the inflammatory infiltration into the cornea ([148]Fig. 8E). The H&E-stained corneal images showed significant corneal thickening with a large number of inflammatory cell infiltration and fiber structure disorder in the control and initial CL groups. In contrast, the corneal structure and thickness in the V[2]C-3@CL–treated group had returned to a healthy state. There was almost no inflammatory cell infiltration with a clear structural hierarchy of the cornea. Fig. 8. Electroretinography and histological assessment to evaluate therapeutic efficacy of V[2]C-3@CL. [149]Fig. 8. [150]Open in a new tab (A to C) Electroretinography recordings and quantitative analysis of a-wave and b-wave amplitudes of SD rats with corneal infections after different treatments. (D) Immunofluorescence images of IL-1β, IL-6, and TNF-α in SD rat corneal tissue. (E) Images of H&E-stained corneas. (F) qRT-PCR analysis of IL-1β, IL-6, and TNF-α mRNA levels in rat corneal tissues. Data are presented as means ± SD, n ≥ 3, biological replicate, and significances are determined by one-way ANOVA with Tukey’s correction. *P < 0.05, **P < 0.01, and ***P < 0.001. DISCUSSION The increasingly widely used CL is vulnerable to the adhesion of pollutants and pathogens in the tears, leading to bacterial keratitis and other problems. In this work, a face-to-face water transfer printing method was developed to modify V[2]C MXenes onto CL to obtain a transparent coating with multifunctional properties. It was certified in XPS, SEM images, and UV-Vis spectra that uniformly distributed V[2]C coatings formed on CL surfaces pretreated with PEI amination. Water contact angle measurements and water flushing experiments demonstrated that the obtained V[2]C@CL exhibited favorable hydrophilicity and coating stability. In addition, V[2]C@CL showed significant CAT-like, SOD-like, and GPx-like activities, which greatly reduced intracellular ROS in HCECs and the LPS-stimulated inflammatory response in RAW 264.7 cells. Furthermore, V[2]C@CL showed excellent bacteria anti-adhesion and bactericidal effects in resisting biofilm formation. In RNA-seq, the gene expressions highly decreased in bacteria related to biofilm formation, virulence, proliferation, and drug resistance. It was also found that V[2]C@CL mainly damaged the cell membrane and other peripheral structures of bacteria and acted on some metabolic pathways for bactericidal and anti-adhesion properties. Compared with the reported drug-loaded antibacterial or anti-inflammatory CLs ([151]41, [152]42), the V[2]C@CL designed in this work shows the obvious advantage of not changing the body structure of the CLs with well-maintained light transmittance. The convenient modification process and simple composition of V[2]C@CL without additional drug loading highly facilitate its clinical application. In infectious keratitis treatment, V[2]C@CL exhibited much higher bactericidal and anti-inflammatory effects compared to clinical vancomycin eye drops, which effectively protected the structure of corneal tissue. Therefore, this facile material surface modification technology that is independent of the substrate can be widely applied in optical materials and implant surface modification for multiple biological functions. MATERIALS AND METHODS Materials V[2]AlC was purchased from Forsman Scientific Co., Inc. (Beijing, China). TPAOH and HF were purchased from Aladdin (Shanghai, China). PEI was purchased from Macklin (Shanghai, China). CL was purchased from Bausch & Lomb (Shanghai, China). HCECs and RAW 264.7 cells were purchased from the American Type Culture Collection (USA). CCK-8 was purchased from MedChemExpress (USA). Total Antioxidant Capacity Assay Kit, Hydrogen Peroxide Assay Kit, Total Superoxide Dismutase Assay Kit, DNA Damage Assay Kit, and Calcein/PI Cell Viability/Cytotoxicity Assay Kit were purchased from Beyotime (Jiangsu, China). Glutathione Peroxidase Assay Kit was purchased from Leagene (Beijing, China). Mouse IL-1β ELISA Kit, Mouse IL-6 ELISA Kit, and Mouse TNF-α ELISA Kit were purchased from Elabscience (Wuhan, China). E. coli (ATCC 25922) and MRSA (ATCC 43300) strains were obtained from Shanghai Luwei Microbial Science and Technology (Shanghai, China). Characterizations TEM images, HRTEM images, and SAED patterns were acquired using a JEM-2100F instrument (JEOL, Japan). The zeta potential of V[2]C NSs was measured by dynamic light scattering using a Malvern Zetasizer Nano ZS90 (Malvern Instruments Limited, UK). XRD patterns were obtained with a Rigaku SmartLab diffractometer (Rigaku, Japan). XPS was performed on an Escalab 250Xi spectrometer (Thermo Fisher Scientific). The water contact angle was measured by OCA15EC (Dataphysics, Germany). UV-Vis spectrophotometry for transmittance measurements was conducted using a UV-1780 instrument (SHIMADZU, Japan). Coating thickness was tested using a UVISEL PLUS ellipsometer (Horiba, France). The zeta potential of CLs was measured by a SurPASS 3 electrokinetic analyzer (Anton Paar, Austria). Because of the requirement of the instrument on sample size for measuring (2 × 4 cm^2), glass slides with similar surface properties to CLs were used for solid surface zeta potential testing. SEM images and element mapping were obtained with a JSM-7500F microscope (JEOL, Japan). Bacterial and cell fluorescence staining images were acquired using a Leica DMi8 fluorescence microscope (Leica, Germany). Fluorescence imaging of cornea sections for H&E and immunofluorescence staining was conducted using a Leica DM4B fluorescence microscope (Leica, Germany). Preparation of V[2]C MXene NSs V[2]AlC powder (1 g) was added to 30 ml of 40 wt% HF solution for etching at room temperature with magnetic stirring at 50°C for 72 hours. The resulting multilayered V[2]C suspension was centrifuged at 2300g for 10 min, and the supernatant was repeatedly washed with deionized water until the supernatant pH was above 5.0. The obtained lumpy precipitate was added to 40 ml of TPAOH solution and magnetically stirred for 24 hours at room temperature. The residual TPAOH was removed by rinsing three times with deionized water. After centrifuging at 1500g for 50 min, the supernatant was collected to obtain an aqueous solution of V[2]C MXene NSs. Preparation of V[2]C@CL The silicone hydrogel CLs were removed from their packaging, washed with pure water to remove the commercial solution, and then immersed in a 5% PEI solution for 12 hours. Then, 1 ml of V[2]C MXene solution (5 mg/ml) was centrifuged at 10,000 rpm for 1 hour. The resulting precipitate was resuspended in 5 ml of anhydrous ethanol and slowly dripped (0.1 ml/s) into a glass dish containing deionized water. Through the Marangoni effect, the V[2]C MXene NSs rapidly diffused and formed a continuous film at the gas-liquid interface. The PEI-modified CLs were touched to the water surface to transfer the film to the outer CL surfaces and then immediately lifted with V[2]C MXene bonded by electrostatic forces. Then, the CL was folded to protrude from the inner surface, and the V[2]C MXene layer was transferred onto the inner CL surface in the same way. A single-layer V[2]C MXene–coated CL was obtained after drying the surface moisture by nitrogen gas. This process was repeated to obtain double and triple V[2]C MXene layers coated CL, namely, V[2]C-1@CL, V[2]C-2@CL, and V[2]C-3@CL. To compare the performance of V[2]C MXene, MAX phase V[2]AlC, and mV[2]C, the above procedure was repeated using 1 ml of V[2]AlC suspension (5 mg/ml) and 1 ml of mV[2]C suspension (5 mg/ml) to prepare V[2]AlC@CL and mV[2]C@CL, respectively. After preparation, the samples were immersed in sterile deoxygenated water, sealed in containers, and stored at 4°C. To test the stability of the coating, V[2]C-1@CL was rinsed with a water flow (10 ml/s) for 0, 3, 6, and 12 hours. The water contact angle of the samples was measured after each rinse duration to verify the integrity of the coating. Furthermore, V[2]C-1@CL was immersed in HCl (pH 4) and NaOH (pH 10) solutions for 12 hours. Water contact angle measurements were then conducted to verify coating stability. CAT-like, SOD-like, and GPx-like activities of V[2]C@CL CAT-like activity was measured using the Hydrogen Peroxide Assay Kit. First, Fe^2+ was oxidized to Fe^3+ by H[2]O[2] and reacted with dimethylphenol orange to produce a purple product. The amount of purple product was determined by reading absorbance at 560 nm using a microplate reader to indirectly calculate CAT-like activity. Briefly, circular 5-mm-diameter sections were cut from different kinds of CLs. Then, CL samples, H[2]O[2] solution, and H[2]O[2] detection reagent were incubated at 37°C for 60 min. The absorbance at 560 nm was then calculated using a microplate reader (SpectraMax 190, Molecular Devices) to explore the CAT-like activity. CAT-like activity was further assessed by measuring O[2] produced in the presence of 1 mM H[2]O[2]. The O[2] produced upon the addition of each CL group was quantified using the JPB-607A portable dissolved oxygen meter. The SOD-like activity was measured using the Total SOD Activity Test Kit. Xanthine oxidase in the kit reacted with xanthine to generate a superoxide anion, which reduced nitroblue tetrazolium (NBT) to formazan, a blue-colored product with an absorption peak at 560 nm. Briefly, circular 5-mm-diameter sections were cut from different kinds of CLs. Then, CL samples were incubated with NBT/enzyme working solution and reaction initiation solution at 37°C for 30 min. The absorbance at 560 nm was then read using a microplate reader to calculate SOD-like activity. The GPx-like activity was tested using the GPx assay kit. GPx catalyzed the conversion of reduced GSH and H[2]O[2] to GSSG and H[2]O, respectively. The remaining GSH reacted with 5,5′-dithiobis(2-nitrobenzoic acid) to produce the yellow 5-thio-2-nitrobenzoic acid (TNB) product. The amount of produced TNB was measured by reading the absorbance at 422 nm using a microplate reader to determine the reduction of GSH. This allowed the indirect calculation of the GPx-like activity of the samples. Briefly, circular 5-mm-diameter sections were cut from different kinds of CLs. Then, CL samples were incubated with GSH working solution at 37°C for 5 min. Oxidizing working solution was then added and further incubated at 37°C for 30 min. The mixture was centrifuged at 3500g for 10 min after adding 2 ml of acidic precipitant. The supernatant was incubated with GPx assay buffer and benzoic acid color-developing solution for 1 min at room temperature before calculating GPx-like activity by reading absorbance at 422 nm using a microplate reader. Ultraviolet radiation inhibition and T-AOC of V[2]C@CL CL samples were placed in 1 ml of PBS in microcentrifuge tubes and irradiated under a 365-nm UV lamp for 30 min at a dose of 20 J/cm^2. In the following exposure, 0.5 mM TMB substrate was added to each tube. The absorbance at 652 nm was subsequently measured using a microplate reader. T-AOC was measured using the Total Antioxidant Capacity Assay Kit. ABTS could be oxidized to green ABTS+ by an oxidant, which could be inhibited by antioxidants. The amount of produced ABTS+ was measured by a microplate reader with absorbance at 414 nm to calculate T-AOC. Briefly, circular 5-mm-diameter sections were cut from different kinds of CLs. Then, the CL samples, peroxidase working solution, and ABTS working solution were incubated together at 37°C for 60 min. The CL samples were then removed and T-AOC was calculated by reading absorbance at 414 nm using a microplate reader. Cytocompatibility of V[2]C@CL Both cell viability assay kit (CCK-8) and live/dead cell staining assays were used to evaluate the cytocompatibility of V[2]C@CL. Briefly, HCECs were inoculated into 96-well plates at 10,000 cells per well. The plates were incubated in a cell culture incubator (37°C, 5% CO[2]) for 12 hours. Sterile 5-mm-diameter circular sections were cut from the different kinds of CLs and placed into wells for 24-hour incubation. For the positive control, 10 μl of dimethyl sulfoxide was added to the wells. Then, 100 μl of CCK-8 solution was added to each well and incubated for 1 to 4 hours. A microplate reader was used to measure the produced crystal at 450 nm. Furthermore, the cytocompatibility of the samples was evaluated using a live/dead staining method. HCECs were seeded in 96-well plates at 10,000 cells per well and incubated for 12 hours. CL samples were then added to the wells for 24-hour incubation. Last, the cells were stained with calcein/PI and imaged under a fluorescence microscope (DMi8, Leica) to observe cell viability. In vitro antioxidant and anti-inflammatory properties of V[2]C@CL HCECs were seeded in 96-well plates at 10,000 cells per well and incubated for 12 hours. The medium was removed and replaced with 90 μl of fresh medium and 10 μl of 10 mM H[2]O[2] solution per well. The 5-mm-diameter circular CL samples were added to the wells and incubated with HCECs for 12 hours. Then, the cells were stained with DCFH-DA and visualized under an inverted fluorescence microscope (DMI8, Leica). In addition, the antioxidant properties of the samples were further evaluated using a DNA damage detection kit. After incubation of cells with different kinds of CLs and H[2]O[2] as described, immunofluorescent staining for the DNA damage marker γ-H2AX was performed using the kit. The cells were harvested and subsequently imaged under an inverted fluorescence microscope (DMI8, Leica). In vitro anti-inflammatory capacity was determined by immunofluorescence staining of inflammatory factors and ELISA. For immunofluorescence staining, the RAW 264.7 cells were seeded in 24-well plates at 50,000 cells per well and incubated for 12 hours. The CL samples were added to the wells and the cells were stimulated with LPS (1 μg/ml) for 4 hours. After removing the CLs, immunofluorescent staining of inflammatory cytokines (IL-1β, IL-6, and TNF-α) was performed to acquire images using a fluorescence microscope (DM4B, Leica). Antibodies used for immunofluorescence are listed in table S3. For the ELISA assay, the RAW 264.7 cells were seeded at 50,000 cells per well and incubated for 12 hours before adding CL samples. The CL samples were added to the wells and the cells were stimulated with LPS (1 μg/ml) for 4 hours. For the negative control group, cells were incubated for 4 hours without any treatment. After the incubation, the cell culture medium was collected from each group. Levels of IL-1β, IL-6, and TNF-α were measured by ELISA kit. Anti-adhesive, bactericidal, and anti-biofilm properties of V[2]C@CL The anti-adhesive of V[2]C@CL was determined using a spread plate method. Logarithmic growth phase (log-phase) MRSA and E. coli were diluted to 1 × 10^6 colony-forming units (CFU)/ml. CL samples were cut into 5-mm-diameter discs and placed into 96-well plates with 200 μl of bacterial suspension per well. Plates were incubated at 37°C for 24 hours. The CL samples were carefully recovered and washed three times with PBS to remove unbound bacteria, and then transferred to sterile centrifuge tubes with 1 ml of PBS. Tubes were sonicated for 10 min and vortexed for 2 min to detach surface-adhered bacteria. MRSA suspensions and E. coli suspensions were 1000-fold and 10,000-fold diluted, respectively, followed by plating to enumerate CFU. The anti-adhesive ability was further examined by crystal violet staining, live/dead bacterial staining, and SEM observation. CL samples in each group were incubated with log-phase MRSA and E. coli at 37°C for 24 hours. After incubation, planktonic bacteria were gently washed away with PBS. After staining of CLs with crystal violet, the stain was solubilized with 30% acetic acid to evaluate the remained bacteria at the absorbance at 590 nm. In the live/dead bacterial staining test, the incubated CLs were gently washed with PBS and then stained with a SYTO 9/PI dye mixture for visualization and imaging using TCS-SP8 confocal laser scanning microscopy (Leica, Germany). As for SEM observation, the incubated CLs were fixed in 2.5% glutaraldehyde at 4°C for 12 hours. Samples underwent stepwise dehydration in ethanol solutions (50, 70, 90, 95, and 100%) for 15 min each, followed by drying in a vacuum oven for 24 hours. Dried samples were visualized and imaged using SEM. The bactericidal property of V[2]C@CL was determined using a spread plate method. The log-phase MRSA and E. coli were diluted to 1 × 10^3 CFU/ml. The CL samples were incubated with the bacterial solution for 12 hours, and the number of surviving bacteria was enumerated by plate counting. The anti-biofilm property of V[2]C@CL was determined by live/dead bacterial staining methods. Log-phase MRSA and E. coli were diluted to 1 × 10^6 CFU/ml. CL samples were cut into 5-mm-diameter discs and placed in 96-well plates. Two hundred microliters of bacterial suspension was added to each well and incubated at 37°C for 72 hours to form biofilms with renewal of the bacterial solution every 24 hours. Samples were gently washed twice with PBS and stained with SYTO 9/PI dyes for visualization and capturing of 3D biofilm images using TCS-SP8 confocal laser scanning microscopy (Leica, Germany). RNA-seq analysis Log-phase MRSA and E. coli were diluted to 1 × 10^6 CFU/ml. Then, CL and V[2]C-3@CL were separately incubated with 5-ml aliquots of the bacterial solution at 37°C for 12 hours. The bacterial solutions were harvested to extract the total RNA. The concentration and purity of the extracted RNA were assessed using an Agilent 2100 Bioanalyzer. The complementary DNA (cDNA) was synthesized by reverse transcription and specific libraries and enriched by polymerase chain reaction (PCR). Sequencing was performed on Illumina NovaSeq 6000 platform by Shanghai Personal Biotechnology Co. Ltd. The raw data underwent quality assessment and filtration using fastp (version 0.22.0), to eliminate reads with adapters, ploy-N, and low quality. Subsequent analyses relied on the resultant high-quality clean data. The reference genome index was built with Bowtie2 and the filtered reads were aligned to the reference genome. The gene read count values were determined by HTSeq (version 0.9.1), representing the initial gene expression levels. Normalization of gene expression across various genes and samples was used by FPKM (fragments per kilobase of exon per million fragments mapped). DESeq (version 1.38.3) discerned differentially expressed mRNAs, with transcripts meeting |log[2]FoldChange| > 1 and P value < 0.05 deemed significant. GO enrichment analysis was performed using the topGO package to determine biological functions enriched among differentially expressed genes. GO terms with P values under 0.05 were considered statistically significantly enriched. The ClusterProfiler package (version 4.6.0) was used for KEGG pathway enrichment analysis of differentially expressed genes to identify signaling pathways showing significant enrichment (P < 0.05). In vivo biocompatibility of V[2]C@CL Six-week-old male SD rats weighing approximately 150 g were purchased from the Animal Administration Center of Wenzhou Medical University (Wenzhou, China). The rats were single-housed in an environment maintained at 25° ± 2°C temperature, 50 ± 5% relative humidity, and a 12-hour light/dark cycle. Standard rodent chow and filtered water were provided ad libitum. All animal experiments were approved by the Institutional Animal Care and Use Committee of Wenzhou Medical University under protocol number wydw2021-0484. The procedures were carried out in strict accordance with the ARRIVE 2.0 guidelines. Nine rats in good health with similar weight were selected to ensure that they were free of ocular diseases and were randomly divided into three groups for PBS, initial CL, and V[2]C@CL daily treatment. Specifically, 5 μl of PBS was dropped on the ocular surface of rats twice a day in the control group. The rats were fitted with initial CL and V[2]C-3@CL for 12 hours daily for a period of 10 days. IOP, tear film breakup time, and slit lamp examinations were conducted before treatment as baseline and on days 1, 3, 5, 7, and 10 after different treatments. After completion of the examination on day 10, tear secretion was examined using the Schirmer test in each group. The rat in each group was randomly selected for cervical dislocation and execution. Corneal tissues were fixed in 4% paraformaldehyde (PFA), embedded in optimal cutting temperature compound, sectioned, and subsequently stained with H&E. Infectious keratitis treatment SD rats of similar weight with healthy corneas were selected. A 3-mm-diameter region of the central corneal epithelium was scraped off. Subsequently, 10 μl of log-phase MRSA bacteria at 1 × 10^7 CFU/ml was applied to the corneal defects, and the eyelids were closed. After 24 hours of incubation, a slit lamp examination was performed to observe the rat corneas to obtain keratitis eyes with uniform infection degree. Rats that had successfully developed keratitis were then randomly divided into four treatment groups using a random number generator, with five rats in each group, for the different interventions. The four groups included the control group (no treatment), initial CL group (fitted 12 hours/day), vancomycin group (5 μl of 5% vancomycin topical administration twice daily), V[2]C-3@CL group (fitted V[2]C-3@CL, 12 hours/day). The total treatment duration was 5 days. During the experiment, any rats that died or sustained corneal ruptures were excluded. On days 1, 3, and 5, slit lamp examination was performed to observe the corneal transparency. The corneal thickness was also measured using a SP-3000 pachymeter (Tomey, Japan). Corneal inflammation was scored on the basis of seven criteria as previously reported (table S2) ([153]43). On day 5, electroretinography assays were done with a RETI-Port21 system (Roland, Germany). Rats were euthanized by cervical dislocation for eyeball removal. To quantify the viable bacteria remaining in corneas following various treatments, the corneal tissues were homogenized in 0.5 ml of sterile solution and serially diluted 100-fold. Aliquots of 100 μl from the dilutions were plated on agar and incubated at 37°C for 12 hours. Bacterial colonies were subsequently enumerated and photographs were acquired. Histopathological evaluation and qRT-PCR analysis The corneal inflammation levels were evaluated via H&E-stained sections, immunofluorescence detection, and qRT-PCR quantification of IL-1β, IL-6, and TNF-α expression measurement. The eye samples were fixed in 4% PFA at 4°C for 1 hour. The corneas were excised along the corneoscleral margins using microscopic scissors. The obtained corneal samples underwent gradient dehydration at 4°C for 2 hours in 10, 20, and 30% sucrose solutions. The corneal tissues were embedded in an optimal cutting temperature compound. The tissues were sectioned into 10-μm slices using a frozen sectioning machine and transferred onto slides. The sections were stained with H&E and immunofluorescence. Antibodies used for immunofluorescence are listed in table S3. The tissue morphology was photographed and observed under a fluorescence microscope (DM4B, Leica). For qRT-PCR measurement, corneal tissues were homogenized and total corneal RNA was extracted for reverse transcription to obtain cDNA. Then, qRT-PCR experiments were performed using the Taq Pro Universal SYBR Green qPCR Master Mix kit (Q712-02, Vazyme, Nanjing, China) to detect IL-1β, IL-6, and TNF-α gene expressions. The sequences of forward and reverse primers for cytokines testing are listed in table S4. Statistical analysis All data were analyzed statistically using GraphPad Prism software (version 9.3.0). One-way analysis of variance (ANOVA) was used for comparisons between multiple groups. Statistical significance was defined as P < 0.05, with varying levels indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Acknowledgments